Logo Medical XPRT
Companies
Products
Services
Software
Training
Applications
Sign in
List your business

Advertising options
  1. Home
  2. News
  3. cardiovascular heart disease
Show results for
Products
Applications

Companies

News
Articles

Refine by
Date

  • Older

Cardiovascular Heart Disease Articles & Analysis

15 news found

CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays

CD BioSciences Announces Comprehensive Circulatory System Tissue Microarrays

This offering accelerates researchers’ studies of diseases related to arterial tissue. Another example is the Cardiovascular Disease Tissue Microarray, 48 Cases, 24 Cores (Catalog # CSCT003), which consists of samples of cardiovascular disease tissue. It comprises 9 cases of cardiovascular ...

ByCD BioSciences


Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

Expanding Possibilities: CD Formulation Unveils Comprehensive Selection of 90+ Active Pharmaceutical Ingredients

Antibacterial, Anti-inflammatory and Antiviral SeriesIn response to the global threat of infectious diseases, CD Formulation has developed a comprehensive range of APIs with antibacterial, anti-inflammatory and antiviral properties. ...

ByCD Formulation


CardioWise™ Receives ISO 13485:2016 Clearance for Design, Development, and Marketing of Software as a Medical Device (SaMD) For the Medical Device Industry

CardioWise™ Receives ISO 13485:2016 Clearance for Design, Development, and Marketing of Software as a Medical Device (SaMD) For the Medical Device Industry

CardioWise, Inc., is pleased to announce that Perry Johnson Registrars, Incorporated has audited the CardioWise Quality Management System (QMS) and determined CardioWise is in conformance with ISO 13485:2016. Perry Johnson Registrars Certificate C2022-02910 was issued July 16, 2022, and represents the first step in the process of obtaining a CE mark and Medical Device Registration for the ...

ByCardioWise Inc.


Todd C. Villines, M.D. Joins Elucid as new Chief Medical Officer

Todd C. Villines, M.D. Joins Elucid as new Chief Medical Officer

A distinguished professor of medicine, clinical cardiologist, and researcher focused on cardiovascular imaging and prevention, Dr. Villines is board-certified in internal medicine, cardiovascular diseases, cardiac computed tomography, and advanced adult echocardiography. ...

ByElucid


Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy

Robocath’s joint venture, Cathbot, concludes first clinical study in China to evaluate robotic PCI safety and efficacy

This technology will benefit doctors and many patients living with cardiovascular diseases all over the country: today, in China, more than 1 million procedures are performed annually across roughly 2,000 PCI centers,” noted Professor Yining Yang, dean of the People’s Hospital of Xinjiang Uygur Autonomous Region. ...

ByRobocath


One-stop Mitochondria-focused Testing Services Targeting to Preclinical Studies of Cardiac Diseases

One-stop Mitochondria-focused Testing Services Targeting to Preclinical Studies of Cardiac Diseases

With its ready-to-use models and assays for cardiac diseases, customers can accurately analyze the relationship between diseases and mitochondria. Mitochondrial DNA (mtDNA) plays an important role in the pathogenesis of the cardiovascular disease (CVD), especially in heart failure and ischemic ...

ByCreative Biogene-Mitochondrial Research


Robocath successfully completes first robotic coronary angioplasty with R-One in China

Robocath successfully completes first robotic coronary angioplasty with R-One in China

Robocath, a company that designs, develops and commercializes innovative robotic platforms for the treatment of vascular diseases, today announces the successful completion of the first coronary angioplasty in China assisted by its R-One™ robotic platform. ...

ByRobocath


Strong antioxidant `bilirubin` to be developed as a disease treatment for the first time

Strong antioxidant `bilirubin` to be developed as a disease treatment for the first time

“We will make ‘bilirubin,’ a substance with antioxidant effects that removes harmful free radicals, as a disease treatment for the first time in the world.” “Over 20,000 papers since 1987 have shown that bilirubin has a therapeutic effect on various diseases,” said Myung-Lip Kim, CEO of Bilix, a bio company developing new ...

ByBilix Co., Ltd.


Medtronic to Acquire Avenu Medical

Medtronic to Acquire Avenu Medical

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the planned acquisition of Avenu Medical, a privately held medical device company based in San Juan Capistrano, Calif. focused on the endovascular (minimally invasive) creation of arteriovenous (AV) fistulae for patients with end-stage renal disease (ESRD) undergoing dialysis. Terms of the transaction were not ...

ByMedtronic


CardioWise Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ) Receives Patents from Both the United States and the European Union

CardioWise Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ) Receives Patents from Both the United States and the European Union

CardioWise, Inc., is pleased to announce two significant patents protecting its heart function analysis software, Stretch Quantifier for Endocardial Engraved Zones (SQuEEZ). The European Union Patent Number 12839978.9 was awarded on February 2, 2019, followed closely by the U.S. Patent on June 7, 2019 (patent application number 14/350,991). Both patents are entitled “Methods for Evaluating ...

ByCardioWise Inc.


CardioWise™ Acquires Worldwide Rights to Patent, and Software to Guide Cardiac Resynchronization Therapy Through License Agreement with Johns Hopkins Technology Ventures

CardioWise™ Acquires Worldwide Rights to Patent, and Software to Guide Cardiac Resynchronization Therapy Through License Agreement with Johns Hopkins Technology Ventures

The SQuEEZ technology is based on the ability to track the heart wall as it moves during the contraction of the heart to allow quantitative assessment of regional heart wall motion from cardiac CT data. ...

ByCardioWise Inc.


Seahorse Executive Jay Teich Receives SFRBM CEO Innovator Award

Seahorse Executive Jay Teich Receives SFRBM CEO Innovator Award

Seahorse Bioscience XF technology is complementary to Agilent's separations and mass spectrometry solutions, providing a more comprehensive and faster path to researching some of the most challenging diseases affecting humankind. Scientists can now gain a greater understanding of redox biology-the study of electron flow through biological circuits, sensors, and ...

ByAgilent Technologies, Inc.


Aircraft noise at night can result in dysfunction of blood vessels and cause long-term cardiovascular disease

Aircraft noise at night can result in dysfunction of blood vessels and cause long-term cardiovascular disease

As these physical changes are potential pathways to high blood pressure, heart and circulatory disease over the long term, reducing night-time aircraft noise is important for preventing cardiovascular disease in people living near airports. Aircraft noise tends to be more annoying and disruptive to sleep than road and rail ...

ByEuropean Commission, Environment DG


Saneron and USF Patent Method for Umbilical Cord Blood Cell Use

Saneron and USF Patent Method for Umbilical Cord Blood Cell Use

Researchers at Saneron CCEL Therapeutics, Inc. of Tampa, Florida, (www.saneron-ccel.com) and the University of South Florida have received a patent relating to a method for obtaining and using umbilical cord blood cells from a donor or patient to provide neural cells for transplantation aimed at repairing a variety of neurodegenerative diseases of the brain and spinal cord, such ...

BySaneron CCEL Therapeutics, Inc.


EPA warns, “children act fast...so do poisons,” in observance of poison prevention week / national awareness campaign planned for March 20-26 to reduce poisonings in U.S.

Adults are also susceptible to poisoning (intentional or unintentional), but from generally different sources, including pain medicines, sedatives (drugs to reduce anxiety), sleeping pills, antipsychotics used to treat mental illness, household cleaning products, antidepressants, cardiovascular drugs (drugs to treat heart disease) and alcohols. ...

ByUS EPA - Environmental Protection Agency

  • Previous
  • Next
Need help finding the right suppliers?Try XPRT Sourcing. Let the XPRTs do the work for you
Back to top
About Medical XPRT

Medical XPRT is a global marketplace with solutions and suppliers for the medical sector, with product catalogs, articles, industry events, publications & more.

Channels

Solutions

  • Medical Equipment & Supplies
  • Medical Software
  • Medical Training Courses
  • Medical Industry Services
  • Medical Product Applications

Latest

  • Medical Industry News
  • Medical Industry Events

Publications

  • Medical Industry Articles & Case Studies
  • Medical Industry Books and Publications
  • Medical Industry Journals and Magazines
  • Medical Industry Downloads
  • Medical Industry Videos

Companies

  • Medical Industry Suppliers & Manufacturers

  • FAQs
  • Company sitemap
  • Category sitemap
Medical XPRT is part of XPRT Media All Rights Reserved.
Terms
Privacy
  • Medical XPRT RSS List
Our sites:
Environmental XPRT
Agriculture XPRT
Energy XPRT
XPRT